Bronchiectasis is a chronic respiratory disease. People with the condition experience difficulty in clearing mucus from their lungs, leaving them prone to infections. Oral steroids have a place in the management of acute and severe asthma. In bronchiectasis, inhaled steroids have small benefits but there is no evidence for or against the use of oral steroids for this condition.
Vollständige Zusammenfassung lesen
Inflammation plays a significant role in the pathophysiology of bronchiectasis. Two small studies have shown small benefits from inhaled corticosteroids and oral corticosteroids may be of benefit in bronchiectasis
Zielsetzungen
To determine the efficacy of oral corticosteroids in acute and stable bronchiectasis
Suchstrategie
The Cochrane Airways Group Specialised Register was searched and bibliographies of retrieved papers were checked. Searches are current as of May 2011.
Auswahlkriterien
Only randomised controlled trials were considered
Datensammlung und ‐analyse
No trials met the inclusion criteria for the review.
Hauptergebnisse
No randomised controlled trials were identified
Schlussfolgerungen der Autoren
There are no randomised trials upon which to base recommendations about the use of oral corticosteroids in acute or stable bronchiectasis.
